Kahn Brothers Group Inc. Makes New $8.30 Million Investment in GSK PLC Sponsored ADR $GSK
MarketBeat
Kahn Brothers Group Inc. acquired a new stake in GSK PLC Sponsored ADR (NYSE:GSK - Free Report) in the 2nd quarter, according to the company in its most recent filing with the SEC. The firm acquired 158,438 shares of the pharmaceutical company's stock, valued at approximately $8,305,000. GSK compri
NYSE:GSK